PMID- 37953603 OWN - NLM STAT- MEDLINE DCOM- 20231201 LR - 20231217 IS - 1521-0758 (Electronic) IS - 0191-3123 (Linking) VI - 47 IP - 6 DP - 2023 Nov 2 TI - The Sonic hedgehog pathway inhibitor GDC0449 induces autophagic death in human Medulloblastoma Daoy cells. PG - 529-539 LID - 10.1080/01913123.2023.2270676 [doi] AB - Medulloblastoma (MB) is a frequently occurring malignant brain tumor in children, and many of these tumors are identified by the abnormal activation of the Sonic Hedgehog (SHH) pathway. Although the Shh inhibitor GDC0449 initially shows some effectiveness in certain tumors, they eventually recur due to drug resistance mechanisms, highlighting the need for new treatment options. In this study, we explore whether GDC0449 induces autophagy in the human MB cell lines. To investigate the ultrastructural pathology changes of GDC0449-treated Daoy and D283 cells, we employed Transmission Electron Microscopy (TEM) technology to identify the expression of autophagic vacuoles. Our results indicate that GDC0449 only increases autophagy in Daoy cells by increasing the LC3-II/LC3-I ratio and autophagosome formation.We also analyzed Beclin1, LC3, Bax, and Cleaved-caspase3 protein and mRNA expression levels of autophagic and apoptotic markers using fluorescence confocal microscopy, RT-PCR, and Western blot. We found that cell autophagy and apoptosis increased in a dose-dependent manner with GDC0449 treatment. Additionally, we observed increased mammalian target of rapamycin (mTOR) phosphorylation and decreased protein kinase B (AKT/PKB), Ribosomal Protein S6, eIF4E-binding protein (4EBP1) phosphorylation in GDC0449-treated Daoy cells. It was observed that inhibiting autophagy using Beclin1 siRNA significantly blocked the apoptosis-inducing effects of GDC0449, suggesting that GDC0449 mediates its apoptotic effects by inducing autophagy.Our data suggests that GDC0449 inhibits the growth of human MB Daoy cells by autophagy-mediated apoptosis. The mechanism of GDC0449-induced autophagy in Daoy cells may be related to the inhibition of the PI3K/AKT/mTOR signaling pathway. FAU - Zhang, Qi AU - Zhang Q AD - Ultrastructural Pathology, Beijing Neurosurgical Institute, Beijing, China. FAU - Zou, Wanjing AU - Zou W AD - Neuropathology, Beijing Neurosurgical Institute, Beijing, China. FAU - He, Longtao AU - He L AD - Ultrastructural Pathology, Beijing Neurosurgical Institute, Beijing, China. FAU - Zhang, Cuiping AU - Zhang C AD - Ultrastructural Pathology, Beijing Neurosurgical Institute, Beijing, China. FAU - Wang, Ying AU - Wang Y AD - Neural Reconstructional Department, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. LA - eng PT - Journal Article DEP - 20231130 PL - England TA - Ultrastruct Pathol JT - Ultrastructural pathology JID - 8002867 RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - 0 (Hedgehog Proteins) RN - 0 (HhAntag691) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - 0 (Beclin-1) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Child MH - Humans MH - Proto-Oncogene Proteins c-akt/metabolism/pharmacology MH - Hedgehog Proteins/pharmacology MH - Phosphatidylinositol 3-Kinases/metabolism/pharmacology MH - Beclin-1/pharmacology MH - *Medulloblastoma/drug therapy MH - Signal Transduction MH - TOR Serine-Threonine Kinases/metabolism/pharmacology MH - Apoptosis MH - Autophagy MH - *Cerebellar Neoplasms/drug therapy MH - Cell Line, Tumor OTO - NOTNLM OT - Apoptosis OT - GDC0449 OT - MB OT - PI3K/Akt/mTOR OT - autophagy EDAT- 2023/11/13 06:43 MHDA- 2023/12/01 06:44 CRDT- 2023/11/13 03:39 PHST- 2023/12/01 06:44 [medline] PHST- 2023/11/13 06:43 [pubmed] PHST- 2023/11/13 03:39 [entrez] AID - 10.1080/01913123.2023.2270676 [doi] PST - ppublish SO - Ultrastruct Pathol. 2023 Nov 2;47(6):529-539. doi: 10.1080/01913123.2023.2270676. Epub 2023 Nov 30.